$54.24
-0.75-1.36%
At close: -
$54.24
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
PTC Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:PTCT | Benzinga
PTC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 24
EPS Estimate
$-1.440
Quarterly Revenue Estimate
$480.18M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$806.78M
Analyze the earnings history of PTC Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTCT | PTC Therapeutics | -$1.20 | -$1.44 | — | — | $210.12M | $480.18M | — | — | 04/24/2025 | Get Alert |
| PTCT | PTC Therapeutics | -$0.24 | -$0.65 | -$0.85 | -30.77% | $307.06M | $248.99M | $213.17M | -14.39% | 02/27/2025 | Get Alert |
| PTCT | PTC Therapeutics | -$1.76 | -$1.44 | -$1.39 | 3.47% | $196.58M | $172.65M | $196.79M | 13.98% | 11/07/2024 | Get Alert |
| PTCT | PTC Therapeutics | -$1.48 | -$1.05 | -$1.29 | -22.86% | $213.81M | $185.87M | $186.70M | 0.45% | 08/08/2024 | Get Alert |
| PTCT | PTC Therapeutics | -$1.88 | -$1.24 | -$1.20 | 3.23% | $220.38M | $169.70M | $210.12M | 23.82% | 04/25/2024 | Get Alert |
| PTCT | PTC Therapeutics | -$1.89 | $0.50 | -$0.24 | -148.00% | $167.41M | $321.29M | $307.06M | -4.43% | 02/29/2024 | Get Alert |
| PTCT | PTC Therapeutics | -$1.53 | -$1.17 | -$1.76 | -50.43% | $217.13M | $210.19M | $196.58M | -6.48% | 10/26/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$2.13 | -$1.58 | -$1.48 | 6.33% | $165.53M | $213.95M | $213.81M | -0.07% | 08/03/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$1.78 | -$1.39 | -$1.88 | -35.25% | $148.74M | $182.62M | $220.38M | 20.68% | 04/27/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$2.03 | -$1.59 | -$1.89 | -18.87% | $165.23M | $189.14M | $167.41M | -11.49% | 02/21/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$1.89 | -$1.19 | -$1.53 | -28.57% | $138.74M | $186.90M | $217.13M | 16.17% | 10/27/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.68 | -$1.33 | -$2.13 | -60.15% | $116.68M | $162.09M | $165.53M | 2.12% | 08/04/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.83 | -$1.51 | -$1.78 | -17.88% | $117.94M | $147.06M | $148.74M | 1.14% | 05/03/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.08 | -$1.64 | -$2.03 | -23.78% | $118.86M | $150.83M | $165.23M | 9.55% | 02/22/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.03 | -$1.40 | -$1.89 | -35.00% | $118.40M | $126.44M | $138.74M | 9.73% | 10/28/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$2.62 | -$1.82 | -$1.68 | 7.69% | $75.24M | $110.50M | $116.68M | 5.59% | 07/29/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$1.81 | -$1.51 | -$1.83 | -21.19% | $68.26M | $98.80M | $117.94M | 19.37% | 05/04/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$1.37 | -$0.94 | -$1.08 | -14.89% | $96.46M | $111.36M | $118.86M | 6.74% | 02/25/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$1.06 | -$0.04 | -$1.03 | -2475.00% | $71.42M | $111.88M | $118.40M | 5.83% | 10/29/2020 | Get Alert |
| PTCT | PTC Therapeutics | -$0.75 | -$1.30 | -$2.62 | -101.54% | $85.52M | $82.78M | $75.24M | -9.11% | 08/05/2020 | Get Alert |
| PTCT | PTC Therapeutics | -$1.29 | -$1.31 | -$1.81 | -38.17% | $53.58M | $81.94M | $68.26M | -16.70% | 04/30/2020 | Get Alert |
PTC Therapeutics (PTCT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.85 | $-0.65 | -30.8 % |
| Q3 | 2024-11-07 | $-1.39 | $-1.44 | 3.47 % |
| Q2 | 2024-08-08 | $-1.29 | $-1.05 | -22.9 % |
| Q1 | 2024-04-25 | $-1.20 | $-1.24 | 3.23 % |
PTC Therapeutics (PTCT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $213.17M | $248.99M | -14.4 % |
| Q3 | 2024-11-07 | $196.79M | $172.65M | 14.0 % |
| Q2 | 2024-08-08 | $186.70M | $185.87M | 0.45 % |
| Q1 | 2024-04-25 | $210.12M | $169.70M | 23.8 % |
FAQ
When is PTC Therapeutics (NASDAQ:PTCT) reporting earnings?
PTC Therapeutics (PTCT) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for PTC Therapeutics (NASDAQ:PTCT)?
The Actual EPS was $-0.85, which missed the estimate of $-0.65.
What were PTC Therapeutics’s (NASDAQ:PTCT) revenues?
The Actual Revenue was $213.2M, which missed the estimate of $249M.
Browse earnings estimates, EPS, and revenue on all stocks.